PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate Cancer

201574 citationsJournal Articlegreen Open Access

Authors

Good health and well-being

Published in: European Urology Focus

Volume 2, Issue 2, pp. 180-188

Field-Weighted Citation Impact: 6.46